HSCSNCMHealthcare·Medical Devices#124 in industry

HeartSciences Inc.

-39.8% · 90d

$2.01

-0.04 (-1.95%)

After-Hours $2.09(+0.08)

News

No News Yet

Press releases and SEC filings for HSCS will appear here as they are published.

Check back later for updates

Key Data

Market Cap$6.4M

Open$2.06

Prev Close$2.05

Day Range$2.01 – $2.10

52W Range$1.89 – $6.47

Volume20,193

P/E (TTM)—

EPS$-4.49

Dividend Yield—

Beta2.45

Price Target$10.00(+397.5%)

Analyst Ratings

Strong Buy2 analysts

Buy 2Hold 0Sell 0

About

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Healthcare · Medical Devices

15 employees

heartsciences.com